Addison's disease in women is a risk factor for an adverse pregnancy outcome

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 12, 2010, Pages 5249-5257

  Björnsdottir, Sigridur ^a   Cnattingius, Sven ^b   Brandt, Lena ^b   Nordenström, Anna ^a   Ekbom, Anders ^b   Kämpe, Olle ^c   Bensing, Sophie ^a,c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADDISON DISEASE; ADULT; ARTICLE; AUTOIMMUNE THYROIDITIS; CESAREAN SECTION; CONTROLLED STUDY; DELIVERY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; PREGNANCY OUTCOME; PREMATURITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SWEDEN;

EID: 78650052980     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0108     Document Type: Article

References (34)

1. Arlt W, Allolio B 2003 Adrenal insufficiency. Lancet 361:1881-1893
2. Winqvist O, Karlsson FA, Kämpe O 1992 21-Hydroxylase, a major autoantigen in idiopathic Addison's disease. Lancet 339:1559-1562
3. Erichsen MM, Løvås K, Skinningsrud B, Wolff AB, Undlien DE, Svartberg J, Fougner KJ, Berg TJ, Bollerslev J, Mella B, Carlson JA, Erlich H, Husebye ES 2009 Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. J Clin Endocrinol Metab 94:4882-4890
4. Betterle C, Dal Pra C, Mantero F, Zanchetta R 2002 Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 23:327-364
5. Eisenbarth GS, Gottlieb PA 2004 Autoimmune polyendocrine syndromes. N Engl J Med 350:2068-2079
6. Bensing S, Brandt L, Tabaroj F, Sjöberg O, Nilsson B, Ekbom A, Blomqvist P, Kämpe O 2008 Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency. Clin Endocrinol (Oxf) 69:697-704
7. Bergthorsdottir R, Leonsson-Zachrisson M, Odén A, Johannsson G 2006 Premature mortality in patients with Addison's disease: a population-based study. J Clin Endocrinol Metab 91:4849-4853
8. Løvås K, Loge JH, Husebye ES 2002 Subjective health status in Norwegian patients with Addison's disease. Clin Endocrinol (Oxf) 56:581-588 (Pubitemid 34595724)
9. Jacobson DL, Gange SJ, Rose NR, Graham NM 1997 Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 84:223-243
10. Hunt AB, McConahey WM 1953 Pregnancy associated with diseases of the adrenal glands. Am J Obstet Gynecol 66:970-987
11. Albert E, Dalaker K, Jorde R, Berge LN 1989 Addison's disease and pregnancy. Acta Obstet Gynecol Scand 68:185-187
12. Lindsay JR, Nieman LK 2005 The hypothalamic-pituitary-adrenal axis in pregnancy: challenges in disease detection and treatment. Endocr Rev 26:775-799
13. Osler M, Pedersen J 1962 Pregnancy in a patient with Addison's disease and diabetes mellitus. Acta Endocrinol (Copenh) 41:79-87
14. Barker DJ 1993 Maternal nutrition and cardiovascular disease. Nutr Health 9:99-106
15. Benediktsson R, Lindsay RS, Noble J, Seckl JR, Edwards CR 1993 Glucocorticoid exposure in utero: new model for adult hypertension. Lancet 341:339-341 (Pubitemid 23039701)
16. Lunde AS, Lundeborg S, Lettenstrom GS, Thygesen L, Huebner J 1980 The person-number systems of Sweden, Norway, Denmark, and Israel. Vital Health Stat 2:1-59
17. Cnattingius S, Ericson A, Gunnarskog J, Källén B 1990 A quality study of a medical birth registry. Scand J Soc Med 18:143-148 (Pubitemid 20183321)
18. Marsá l K, Persson PH, Larsen T, Lilja H, Selbing A, Sultan B 1996 Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr 85:843-848
19. Høgberg U, Larsson N 1997 Early dating by ultrasound and perinatal outcome.Acohort study. Acta Obstet Gynecol Scand 76:907-912
20. Chuang CH, Velott DL, Weisman CS 2010 Exploring knowledge and attitudes related to pregnancy and preconception health in women with chronic medical conditions. Matern Child Health J 14:713-719
21. Jonasson JM, Brismar K, Sparén P, Lambe M, Nyrén O, Ostenson CG, Ye W 2007 Fertility in women with type 1 diabetes: a population-based cohort study in Sweden. Diabetes Care 30:2271-2276
22. Schneeberg NG 1959 The thyroid gland and infertility. Clin Obstet Gynecol 2:826-836
23. Winqvist O, Gustafsson J, Rorsman F, Karlsson FA, Kämpe O 1993 Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison's disease. J Clin Invest 92:2377-2385
24. Arlt W, Callies F, van Vlijmen JC, Koehler I, Reincke M, Bidlingmaier M, Huebler D, Oettel M, Ernst M, Schulte HM, Allolio B 1999 Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 341:1013-1020 (Pubitemid 29451796)
25. Løvås K, Gebre-Medhin G, Trovik TS, Fougner KJ, Uhlving S, Nedrebø BG, Myking OL, Kämpe O, Husebye ES 2003 Replacement of dehydroepiandrosterone in adrenal failure: no benefit for subjective health status and sexuality in a 9-month, randomized, parallel group clinical trial. J Clin Endocrinol Metab 88:1112-1118 (Pubitemid 36337764)
26. Robinson BG, Emanuel RL, Frim DM, Majzoub JA 1988 Glucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta. Proc Natl Acad Sci USA 85:5244-5248
27. Wadhwa PD, Porto M, Garite TJ, Chicz-DeMet A, Sandman CA 1998 Maternal corticotropin-releasing hormone levels in the early third trimester predict length of gestation in human pregnancy. Am J Obstet Gynecol 179:1079-1085
28. Smith R 2007 Parturition. N Engl J Med 356:271-283
29. Smith R, Smith JI, Shen X, Engel PJ, Bowman ME, McGrath SA, Bisits AM, McElduff P, Giles WB, Smith DW 2009 Patterns of plasma corticotropin-releasing hormone, progesterone, estradiol, and estriol change and the onset of human labor. J Clin Endocrinol Metab 94:2066-2074
30. Wang J, Wicker LS, Santamaria P 2009 IL-2 and its high-affinity receptor: genetic control of immunoregulation and autoimmunity. Semin Immunol 21:363-371
31. Heyder P, Bekeredjian-Ding I, Krienke S, Lorenz HM, Schiller M 2009 Cells induced to undergo apo in the presence of the caspase inhibitor benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone stimulate Moderived phagocytes to secrete proinflammatory cytokines. Autoimmunity 42:328-330
32. Murphy VE, Clifton VL 2003 Alterations in human placental 11β- hydroxysteroid dehydrogenase type 1 and 2 with gestational age and labour. Placenta 24:739-744
33. Barker DJ, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS 1993 Fetal nutrition and cardiovascular disease in adult life. Lancet 341:938-941 (Pubitemid 23109122)
34. Kramer MS 1987 Intrauterine growth and gestational duration determinants. Pediatrics 80:502-511